Breast Imaging: Page 39

Deep learning boosts prediction of breast cancer risk
By Erik L. Ridley
Swedish researchers are convinced an artificial intelligence algorithm that analyzes negative screening mammography exams can produce more accurate forecasts of a woman's future risk of breast cancer than models based on breast density measurements. They published their results online on 17 December in Radiology.
December 17, 2019
2018 08 28 18 59 9066 Artificial Intelligence Ai 400
PET/MRI wins support in breast lesion comparisons
By Wayne Forrest
Researchers from the University of Düsseldorf in Germany have found that the combination of PET with MRI was statistically superior to MRI alone for normal detection and staging of breast cancer, as well as in the detection of distant metastases (M staging). They revealed their findings at RSNA 2019.
December 15, 2019
2016 10 05 17 45 45 493 Breast Cancer 400
German team shows value of FDG-PET/MRI in breast cancer
By Wayne Forrest
A new study from Düsseldorf, Germany, has found that FDG-PET/MRI shows promise for accurate staging of breast cancer, but the modality still isn't as accurate as sentinel lymph node biopsy. The researchers presented their results at RSNA 2019.
December 12, 2019
2017 06 21 16 31 10 974 German Flag Button 400
Is it transphobic for a patient to request a female-born medic?
By Philip Ward
A woman who asked for her U.K. National Health Service breast screening examination to be carried out by a female-born radiographer was referred to as a transphobe by a hospital group, according to a report published on 8 December by the Sunday Times.
December 10, 2019
2019 12 10 22 31 6208 Transsexual Gender 400
Laszlo Tabar receives award from Indian group
By AuntMinnieEurope.com staff writers
The Breast Imaging Society of India has delivered a lifetime achievement award to Dr. László Tabár for his many years of work promoting and investigating the early detection of breast cancer.
December 8, 2019
2019 12 09 22 06 2223 Tabar Laszlo Bisi 20191209224534
Doubts persist over DBT's clinical impact
By Philip Ward
Digital breast tomosynthesis (DBT) is developing fast, but some challenges and questions remain in terms of efficiency, efficacy, safety, and quality assurance, as well as the long-term effect on mortality, two leading researchers have noted in an RSNA 2019 presentation.
December 3, 2019
2016 11 15 14 47 22 735 Breast Dbt 400
What's AI's clinical role in breast screening?
By Edna Astbury-Ward, PhD
The critically important task of showing how artificial intelligence (AI) can enhance patient management surfaced on the first day of RSNA 2019, when the latest clinical evidence of AI's potential contribution in breast screening came under intense scrutiny.
December 1, 2019
2019 12 01 20 30 3281 Halling Brown Ai Breat Rsna 20191201205911
CE Mark extended for Hologic's Localizer
By AuntMinnieEurope.com staff writers
Women's imaging vendor Hologic announced an extension of the CE Mark for its Localizer radiofrequency identification tag for long-term placement.
December 1, 2019
2019 02 01 17 54 2200 Hologic Rsna 2018 400
Add MRI to breast screening for fewer interval cancers
By Rebekah Moan
In a large Dutch study, using supplemental MRI screening in women with extremely dense breast tissue and normal mammograms resulted in significantly fewer interval cancers than using mammography alone.
November 28, 2019
2019 11 27 20 45 2576 Nejm Breast Mri 400
Volpara to feature upgrades, partnerships at RSNA 2019
By AuntMinnieEurope.com staff writers
Breast imaging software developer Volpara Solutions plans to showcase its artificial intelligence-powered clinical-decision support platform for breast cancer screening and highlight two business partnerships at the RSNA 2019 meeting in Chicago.
November 27, 2019
CMR adds to Egyptian installed base
By AuntMinnieEurope.com staff writers
CMR Molecular Imaging, a subsidiary of PET developer Compañía Mexicana de Radiología (CMR) Naviscan, said it has installed its breast PET imaging system at Baheya Breast Cancer Center in Egypt.
November 26, 2019
Perform biennial screening at 45, say European guidelines
By Rebekah Moan
A new set of guidelines from Europe advise that women should be screened for breast cancer every two to three years between the ages of 45 and 74. The authors suggest that the harm caused by annual screening may well outweigh the benefits.
November 26, 2019
2016 08 22 15 18 32 799 Mammogram Patient 400
Previous Page
Page 39 of 139
Next Page